Last checked at 
LONDON (Alliance News) - Venture Life Group PLC said Wednesday it has signed new long-term distribution agreements with two distribution partners for the distribution of four Venture Life products in three territories.
The consumer self-care group, which focuses on developing, manufacturing and commercialising products for the ageing population, said the NeuroAge NRG and NeuroAge Sleep products signed with an existing partner in Romania and Moldova; ZipClear and Calm-eze signed with a new partner in Turkey.
A new long-term distribution agreement has been signed with MedMen for the NeuroAge NRG and NeuroAge Sleep products - two new line extensions for the NeuroAge range. MedMen already owns distribution rights for NeuroAge in Romania and Moldova and has now acquired the rights for NeuroAge NRG and NeuroAge Sleep for distribution, also in Romania and Moldova, said Venture Life
Distribution agreements have also been signed for the company's ZipClear and Calm-eze products with distribution company GM-BAY, for distribution in Turkey. Market launch is expected in the first quarter of next year, following registration.
Following the successful first commercialisation of Procto-eze, Immobilice, and Guma-eze, announced on April 23, 2014, the commercialisation of ZipClear is further evidence of tangible synergies arising from the Biokosmes acquisition, said Venture Life, which completed earlier in 2014.
No financial terms of the deal were disclosed.
Shares in Venture Life were quoted at 100 pence per share Wednesday morning, untraded.
By Alice Attwood; aliceattwood@alliancenews.com; @AliceAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
